![](//s1.studylibfr.com/store/data-gzf/ab2ff21e88ab241d3cf2477979d315e4/1/009396338.htmlex.zip/bg5.jpg)
Results
II
3MATERIALSANDMETHODS..................................................................................................41
3.1MATERIALSUSEDINTHISSTUDY...................................................................................................41
3.1.1Humancolorectalcancercelllines................................................................................41
3.1.2Primarycolorectaltumorsamples.................................................................................43
3.1.3Antibodies......................................................................................................................43
3.1.4Primers...........................................................................................................................44
3.2METHODSUSEDINTHISSTUDY.....................................................................................................45
3.2.1Microarraydata.............................................................................................................45
3.2.1.1mRNAexpressionmicroarrayanalysis......................................................................45
3.2.1.2DNAmethylationmicroarrayanalysis.......................................................................45
3.2.2Identificationofgenes...................................................................................................46
3.2.2.1AssociationsbetweenmRNAexpressionandthedoublingtimeofcelllines...........46
3.2.2.2AssociationsbetweenmRNAexpressionandpromotermethylationlevels............46
3.2.3Functionalgroupenrichmentanalysis...........................................................................46
3.2.4Invitroexperiments.......................................................................................................47
3.2.4.1Determinationofthedoublingtime.........................................................................47
3.2.4.2Proliferationassay.....................................................................................................47
3.2.4.3Growthinhibitionassay.............................................................................................48
3.2.4.4Apoptosisandcellcycleanalysis...............................................................................48
3.2.4.5Clonogenicassay........................................................................................................49
3.2.4.6RNAiknockdownofPPOXandGAPDH......................................................................49
3.2.4.7ProteinextractionandWesternblot.........................................................................49
3.2.4.8RNAextractionandquantitativeRT‐PCR..................................................................49
3.2.4.9DNAextractionandbisulfitesequencing..................................................................50
3.2.5ZNF238overexpressionincoloncancercells.................................................................50
3.2.5.1ZNF238cloning..........................................................................................................50
3.2.5.2ZNF238overexpressionincoloncancercells............................................................50
3.2.6Invivoanimalexperiments............................................................................................51
3.2.6.1Drugeffectsinvivousingaxenograftmodel............................................................51
3.2.6.2Determinationofthegradeofdifferentiationofcelllinesinaxenograftmodel.....51
3.2.6.3TheeffectofoverexpressingZNF238incellsinvivousingaxenograftsmodel.......51
4RESULTS................................................................................................................................52
4.1HIGHLYEXPRESSEDGENESINRAPIDLYPROLIFERATINGTUMORCELLSASNEWTARGETSFORCOLORECTAL
CANCERTREATMENT...............................................................................................................................52
4.1.1Proliferationofcolorectalcancercelllines....................................................................52
4.1.2Expressionprofilingofcolorectalcancercelllineswithdifferentgrowthrates............55
4.1.3IdentificationofPPOXandGAPDHasnewcandidatetherapeutictargets...................63
4.1.4InhibitionofPPOXandGAPDHreducesthegrowthofcolorectalcancercellsinvitro.66
4.1.5PPOXinhibitionreducesthegrowthofcoloncancercellsinaxenograftmodel..........73
4.2EXPRESSIONREGULATIONBYEPIGENETICSILENCING.........................................................................75
4.2.1Genome‐wideanalysisofCpGmethylationincolorectalcancercelllines....................75